Literature DB >> 19109113

Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.

Ozgur Kara, Omer Dizdar, Kadri Altundag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19109113     DOI： 10.1001/jama.2008.869

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

2.  Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro.

Authors:  Eric Abhold; Elham Rahimy; Jessica Wang-Rodriguez; Katherine J Blair; Michael A Yu; Kevin T Brumund; Robert A Weisman; Weg M Ongkeko
Journal:  BMC Res Notes       Date:  2011-12-21

3.  Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study.

Authors:  Antonino Mafodda; D Giuffrida; A Prestifilippo; D Azzarello; R Giannicola; M Mare; R Maisano
Journal:  Support Care Cancer       Date:  2017-04-09       Impact factor: 3.603

4.  Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

Authors:  J Glaspy; J Crawford; J Vansteenkiste; D Henry; S Rao; P Bowers; J A Berlin; D Tomita; K Bridges; H Ludwig
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.